Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelin (Msln)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02839681
What this trial is testing

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Who this might be right for
Lung Neoplasms
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT03023722
What this trial is testing

Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Yale University 18
Not applicableLooking for participantsNCT06717022
What this trial is testing

A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

Who this might be right for
Mesothelin Positive Tumors
Tianjin Medical University Cancer Institute and Hospital 24
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Early research (Phase 1)WithdrawnNCT00024687
What this trial is testing

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses

Who this might be right for
Neoplasms
INSYS Therapeutics Inc
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07510802
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Who this might be right for
Breast Cancer (Advanced/Metastatic)HER2-positive Breast CancerTriple-negative Breast Cancer
Beijing Biotech 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03356808
What this trial is testing

Antigen-specific T Cells Against Lung Cancer

Who this might be right for
Lung Cancer
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Ended earlyNCT03455556
What this trial is testing

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Mesothelin PositiveStage III Non-Small Cell Lung Cancer AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7+2 more
Mayo Clinic 1
Not applicableUnknownNCT00155740
What this trial is testing

Mesothelin as a New Tumor Marker for Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Taiwan University Hospital 250
Testing effectiveness (Phase 2)Ended earlyNCT03356795
What this trial is testing

Intervention of CAR-T Against Cervical Cancer

Who this might be right for
Cervical Cancer
Shenzhen Geno-Immune Medical Institute 20
Not applicableStudy completedNCT05372692
What this trial is testing

Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weijia Fang, MD 3
Testing effectiveness (Phase 2)UnknownNCT03615313
What this trial is testing

PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Research Institute 50
Not applicableUnknownNCT00899613
What this trial is testing

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
University Hospital, Caen 270
Early research (Phase 1)Study completedNCT01018784
What this trial is testing

MORAb-009 in Patients With Solid Tumor

Who this might be right for
CancerMesothelin-positive
Eisai Co., Ltd. 17
Not applicableLooking for participantsNCT07010523
What this trial is testing

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Mesothelin-positive Advanced Malignant Solid Tumors
First Affiliated Hospital of Zhejiang University 24
Early research (Phase 1)Study completedNCT02696642
What this trial is testing

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Who this might be right for
Neoplasms
Bayer 54
Testing effectiveness (Phase 2)Looking for participantsNCT07589543
What this trial is testing

Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerEpithelial Ovarian Cancer, Fallopian Tube or Peritoneum
Beijing Biotech 42
Early research (Phase 1)Study completedNCT03054298
What this trial is testing

CAR T Cells in Mesothelin Expressing Cancers

Who this might be right for
Lung AdenocarcinomaOvarian CancerPeritoneal Carcinoma+3 more
University of Pennsylvania 65
Next Page